The similarities between the serotonin (5-HT) transporter in both human platelets and human brain permit us to investigate this structure in patients with different psychiatric disorders. Several reports have shown abnormalities of the 5-HT transporter, by means of the measurement of the 5-HT uptake or of the H-3-imipramine binding, in platelets of patients with obsessive-compulsive disorder (OCD). The availability of the ligand H-3-paroxetine, a selective 5-HT reuptake inhibitor, to label the 5-HT transporter, promoted us to evaluate the binding of H-3-paroxetine in platelets of 18 drug-free patients with OCD. The results, showing that the patients had a lower number of H-3-paroxetine sites, wich is inversely correlated with the Yale Brown Obsessive-Compulsive Scale total score, than a similar group of controls, add supporting evidence to the involvement of 5-HT in OCD. In addition, the decreased functionality of the 5-HT transporter seems to be linked to the severity of OC symptoms.

Decreased platelet H-3-paroxetine binding in obsessive-compulsive patients

ROSSI, ALESSANDRA;GIANNACCINI, GINO;LUCACCHINI, ANTONIO;
1996-01-01

Abstract

The similarities between the serotonin (5-HT) transporter in both human platelets and human brain permit us to investigate this structure in patients with different psychiatric disorders. Several reports have shown abnormalities of the 5-HT transporter, by means of the measurement of the 5-HT uptake or of the H-3-imipramine binding, in platelets of patients with obsessive-compulsive disorder (OCD). The availability of the ligand H-3-paroxetine, a selective 5-HT reuptake inhibitor, to label the 5-HT transporter, promoted us to evaluate the binding of H-3-paroxetine in platelets of 18 drug-free patients with OCD. The results, showing that the patients had a lower number of H-3-paroxetine sites, wich is inversely correlated with the Yale Brown Obsessive-Compulsive Scale total score, than a similar group of controls, add supporting evidence to the involvement of 5-HT in OCD. In addition, the decreased functionality of the 5-HT transporter seems to be linked to the severity of OC symptoms.
Marazziti, D; Rossi, Alessandra; Gemignani, A; Giannaccini, Gino; Pfanner, C; Milanfranchi, A; Presta, S; Lucacchini, Antonio; Cassano, Gb
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/176471
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 47
social impact